Is There a BioZorb Implant Lawsuit?

Yes. BioZorb lawsuits are being pursued against Hologic Inc., over dangerous design defects that may cause the implantable breast tissue markers to migrate or fail to dissolve, resulting in severe pain or the need for removal surgery.

Who qualifies for a BioZorb lawsuit?

Individuals may be eligible for a BioZorb lawsuit settlement if they received an implantable marker and experienced; Migration Erosion Severe pain Swelling Infections Fluid buildup (Seroma) Removal surgery Other complications

Were BioZorb breast tissue markers recalled?

Hologic, Inc. issued a BioZorb Marker recall in the first half of 2024, following numerous reports of serious adverse events including infections, seromas (fluid buildup), device migration, breakage, pain, discomfort, rashes, extended resorption times, and other problems necessitating additional medical interventions to remove the device.

What to do if you have a recalled BioZorb Marker?

The instructions provided by the manufacturer and federal health regulators indicate that individuals with a BioZorb implantable radiographic marker should consult with their healthcare providers if they experience any complications and report any adverse events to both Hologic and the FDA’s MedWatch Adverse Event Reporting program.

What are the problems with BioZorb implants?

Problems with the BioZorb design have been linked to absorption failures, fracture and migration risks, and erosion complications, among others.

What is the BioZorb made of?

The BioZorb is constructed from a bioabsorbable polylactic acid (PLA) that is supposed to dissolve within the body over a defined period. Embedded within the bioabsorbable material are titanium clips meant to remain after the PLA dissolves, marking the tissue site.

How long do BioZorb implants take to dissolve?

The BioZorb Marker used in breast cancer treatments for radiographic marking is designed to dissolve within about 12 months after implantation. However, many who have received a BioZorb marker have reported that the device failed to resolve within this time frame, or at all, leading to severe pain and side effects.

What are the side effects of BioZorb Markers?

BioZorb side effects have been reported in a number of lawsuits filed against the manufacturer, each raising allegations that the device’s design and functionality have resulted in severe pain, swelling and immune responses, infections, migrations, erosions, fluid buildup and necrosis.

Topic Archives: BioZorb

BioZorb Lawsuit

December 02, 2024 By: Austin Kirk

BioZorb lawsuits are being filed against Hologic Inc., claiming the breast tissue markers fail to dissolve or migrate, resulting in severe pain or the need for removal surgery.
Hologic Seeks To Dismiss BioZorb Design Defect Claims in Lawsuits Over Recalled Tissue Marker

November 14, 2024 By: Irvin Jackson

Although a BioZorb recall has been issued for all versions of the breast tissue marker, Hologic is asking the court to throw out claims alleging injuries were caused by design defects.
BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal

November 07, 2024 By: Irvin Jackson

Lawsuit comes days after FDA announced a BioZorb marker recall, indicating the implants are failing to properly be absorbed in women's bodies.
BioZorb Recall Issued for All Breast Tissue Markers Following Implant Migration, Erosion Problems

October 25, 2024 By: Irvin Jackson

Manufacturer will remove all remaining BioZorb Markers from the market, following adverse events and lawsuits filed by women who experienced problems with the breast tissue implant.
Hologic Faces Lawsuit Over BioZorb Complications Experienced by Five Breast Cancer Patients

October 24, 2024 By: Irvin Jackson

Women experienced infections, scarring, device migration and other complications after a BioZorb marker failed to absorb properly, lawsuit claims.
Lawsuit Alleges BioZorb Removal Surgery Likely Needed After Breast Tissue Marker Failed To Reabsorb

October 10, 2024 By: Irvin Jackson

Breast cancer survivor indicates the chemotherapy tissue marker BioZorb did not absorb back into her body, leaving her with severe pain.
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects

September 04, 2024 By: Irvin Jackson

Following pretrial motions for summary judgement, plaintiffs have filed a request to amend their BioZorb implant lawsuit, adding additional details in support of their design defect and failure to warn claims.
BioZorb Injury Lawsuits Are Being Prepared For Trial in July 2025 in District of Massachusetts

August 14, 2024 By: Irvin Jackson

Four lawsuits over BioZorb Marker will be selected for early bellwether trials, to help gauge how juries may respond to evidence that the tissue marker caused painful complications.
BioZorb Implant Complications Result in Lawsuit Brought by 7 Breast Cancer Survivors

July 26, 2024 By: Irvin Jackson

Each of the women experienced severe complications from the BioZorb implant, after the radiographic marker failed to dissolve, migrated or fractured
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal

July 11, 2024 By: Russell Maas

Five different women joined together to file the lawsuit against BioZorb manufacturer, alleging that the recalled breast tissue markers failed to absorb, fractured or failed, causing painful injuries

Motion Filed To Centralize Depo-Provera Lawsuits in Federal MDL Over Brain Tumor Risks (Posted 2 days ago)

A group of plaintiffs have petitioned the U.S. Judicial Panel on Multidistrict Litigation to consolidate all Depo-Provera lawsuits before one federal judge for coordinated pretrial proceedings.

Tepezza Hearing Damage Emerged After 5 Months of IV Infusions for Thyroid Eye Disease: Lawsuit (Posted 2 days ago)

Lawsuit alleges a man suffered permanent hearing loss after several months of IV infusions of Tepezza, indicating that the drug maker delayed adding warnings to the thyroid eye disease drug label.

Caesarstone Faces Lawsuit Filed By Quartz Countertop Cutter Diagnosed With Silicosis (Posted 7 days ago)

A former quartz countertop cutter's silicosis lawsuit indicates that he could have avoided the severe lung damage if warnings had been provided about steps that would have reduced exposure to silica dust.

Topic Archives: BioZorb

BioZorb Lawsuit

Hologic Seeks To Dismiss BioZorb Design Defect Claims in Lawsuits Over Recalled Tissue Marker

BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal

BioZorb Recall Issued for All Breast Tissue Markers Following Implant Migration, Erosion Problems

Hologic Faces Lawsuit Over BioZorb Complications Experienced by Five Breast Cancer Patients

Lawsuit Alleges BioZorb Removal Surgery Likely Needed After Breast Tissue Marker Failed To Reabsorb

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects

BioZorb Injury Lawsuits Are Being Prepared For Trial in July 2025 in District of Massachusetts

BioZorb Implant Complications Result in Lawsuit Brought by 7 Breast Cancer Survivors

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal

More Top Stories

Review A Case